FDA fully approves Moderna COVID-19 vaccine
The Food and Drug Administration (FDA) on Monday granted full approval to Moderna’s COVID-19 vaccine, the company said, giving an additional vote of confidence in its safety and effectiveness.
The full approval for people aged 18 and older was based on follow-up data showing “high efficacy and favorable safety approximately six months after the second dose.” |